AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Inside the mind of a Nobel physicist: John Martinis on the future of quantum computing
2
Check Point raises $1.75 billion, potentially eyeing AI expansion
3
Hapag-Lloyd eyes ZIM acquisition, workers push back
4
Sequoia’s Shaun Maguire says Israel risks losing “a war it can’t see”
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news

Advent

5 stories about Advent
דיוויד מוסאפר שותף מנהל ב אדוונט ו גיא ברנשטיין מנכ"ל פורמולה

Advent bets on cloud transition with $2.5 billion Sapiens acquisition

14.08.25|Almog Azar
Insurtech’s U.S. market ambitions hinge on private equity’s deep network.
רוני על‐דור מנכ"ל ונשיא סאפיינס ו גיא ברנשטיין מנכ"ל פורמולה

Advent to acquire Sapiens for $2.5 billion, ending its public market run

13.08.25|Almog Azar, CTech
Insurance software maker to go private at 64% premium as private equity bets on SaaS and AI transformation.
אסף רזניק אליק איזנברג BigPanda

BigPanda enters unicorn club with $190 million funding at $1.2 billion valuation

12.01.22|Meir Orbach
The IT management company raised the sum in two rounds over a month-and-a-half in late 2021
מנכ"ל פורסקאוט מייקל דסיזאר

Advent Delays $1.9 Billion ForeScout Acquisition

19.05.20|Hagar Ravet
The companies are in ongoing discussions concerning the timing and terms of completion, but, according to ForeScout, there can be no assurance that they could reach an agreement
מפעל טבע הר חוצבים ירושלים

Cerberus, Advent Eye Teva's European Assets, Report Says

15.08.17|Calcalist
The private equity firms are taking an interest in Teva's European oncology and pain treatment assets, estimated at $700 million to 1$ billion, according to a Bloomberg report